Vertically integrated across the European cannabis value chain.
From Swiss indoor cultivation to Dutch licensed cultivation to German medical wholesale, Essence holds operating stakes across the value chain in markets where regulation is firm and licences are scarce.
Essence Investment AG is a Swiss investment company holding controlling stakes in four operating cannabis businesses in Switzerland, the Netherlands and Germany. We acquire, build and govern these companies for the long term.
We focus on jurisdictions where cannabis is moving from prohibition to a regulated framework — and where licence regimes, planning constraints and pharmaceutical compliance create durable barriers to entry.
The European cannabis value chain.
Essence operates across cultivation, manufacturing, wholesale and brand in three regulated jurisdictions.
| Company | Genetics | Cultivation | Wholesale CBD | Manufacturing | Medical cannabis | B2C brand | Retail | Recreational pilot |
|---|---|---|---|---|---|---|---|---|
| Marry Jane AG | — | — | ||||||
| Swiss Extract AG | — | — | ||||||
| Growery B.V. | — | |||||||
| AMP GmbH | — | — | — | — |
Active governance, long-term ownership.
Operating model
Essence acts as an active majority or significant-minority shareholder, providing governance, capital and strategic direction. Operating teams retain day-to-day control.
Selection criteria
We invest where the licence regime is genuinely scarce, where the operating asset is hard to replicate, and where the regulatory direction of travel is clear.
Time horizon
Long-term holding. Essence is not a fund with a fixed exit window — we build and govern these businesses for decades, not vintage years.
A board with backgrounds in private equity, investment banking, Swiss law and global health policy oversees the platform. Meet the board →
A regulated industry deserves a regulated investor.
Essence Investment AG · Switzerland
Get in touch